Chronic Condition Management

Despite its potential to improve quality of life, palliative care remains underused in stroke recovery, especially among Black, Hispanic and Asian populations.

Respondents citing financial hardship as a reason for non-adherence to asthma medications had nearly double the odds of an asthma attack and more than 60% heightened risk of requiring ED care.

Early screening for cancer is critical and PCPs play a major role in educating patients about regular screenings.

How is life different across the pond? UK babies can expect to live longer than newborn Americans.

The cost-effectiveness of using AI-ECG is $27,858 per quality-adjusted life year, and it’s particularly cost-effective in outpatient settings.

The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.

Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.

PCORI announces list of grants to support studies on patient-centered health care.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A study of more than 9,000 patients determined that text message reminders did not improve how regularly they refilled their medications after 12 months.

Study finds that primary care physicians have an opportunity to identify and possibly mitigate dementia long before symptoms become apparent

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Primary care practices handle more than 90% of diabetes cases despite insufficient resources, training and support.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Study found multiple benefits for patients who stay hydrated

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

14 million Americans will have Alzheimer’s disease by 2060, and many cases of cognitive impairment go undetected by PCPs. Key points from a recent summit offer new insights into screening methods.

Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.

Poor mental health can be driven by online browsing choices - but a free tool can help

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Commonwealth Fund examines underinsureds, now more than 20% of the people with health insurance around the country.

Most U.S. adults are in favor of mental health discussions during primary care visits, according to a recent survey.

The U.S. Preventive Services Task Force highlights key research gaps in their recommendations intended to promote public health for all.